PMID: 3750373Jan 1, 1986Paper

Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy

Therapeutic Drug Monitoring
L M OjemannR A Buchanan

Abstract

Zonisamide (CI-912) is an experimental antiepileptic drug. Since this drug is to be evaluated initially as an add-on medication, an investigation was conducted to study its kinetics in the presence of two standard antiepileptic drugs. Patients in two groups, one on maintenance phenytoin (PHT) monotherapy and the other on maintenance carbamazepine (CBZ) monotherapy, each received a single dose of four 100-mg capsules of zonisamide; and blood samples were obtained at periodic intervals. Plasma and red blood cell (RBC) concentrations of zonisamide were measured by high performance liquid chromatography. Plasma and RBC areas under the curve produced by single doses of zonisamide in patients receiving CBZ were significantly higher than those receiving PHT (p less than 0.05). Clearance values, although not statistically significantly different, were lower for the CBZ group; and consistent with this, plasma and RBC concentrations decreased more rapidly in the PHT group. The approximate values for t1/2 were 36.4 h in plasma and 54.2 h in RBC for patients treated with CBZ, and 27.1 h in plasma and 35.8 h in RBC for patients treated with PHT. The RBC/plasma ratio varied eightfold within a given curve. These findings suggest that the dosa...Continue Reading

Citations

Apr 1, 1996·Clinical Biochemistry·A D Fraser
Jul 27, 2001·Neurologic Clinics·S C Schachater
Apr 21, 1999·Epilepsy Research·M OkadaS Kaneko
Jul 15, 2000·Clinical Neuropharmacology·B F Bourgeois
Dec 1, 1996·The Journal of Pharmacy and Pharmacology·I IeiriS Higuchi
Dec 4, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Hugo M NeelsWilly E Lambert
Oct 13, 2000·Fundamental & Clinical Pharmacology·M S Benedetti
Dec 6, 2001·Current Treatment Options in Neurology·Basim M. Uthman, Andreas Reichl
Jan 1, 1995·Pharmacology & Therapeutics·M C Walker, P N Patsalos
Dec 22, 2009·Expert Review of Neurotherapeutics·Cecilie Johannessen Landmark, Philip N Patsalos
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S Arroyo, G Kramer
Mar 9, 2010·Thérapie·Marie-Clémence VerdierUNKNOWN le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
Feb 27, 2007·Epilepsia·Graeme Sills, Martin Brodie
Nov 1, 2012·Acta Neurologica Scandinavica. Supplementum·M J BrodieL Giorgi
Aug 1, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kinga K BorowiczStanisław J Czuczwar
Apr 28, 2005·Expert Review of Neurotherapeutics·Victor Biton
Oct 30, 2004·Seizure : the Journal of the British Epilepsy Association·Martin J Brodie
Oct 30, 2004·Seizure : the Journal of the British Epilepsy Association·Ilo E Leppik
Sep 8, 2005·Psychosomatics·Neil B SandsonKelly L Cozza
Apr 16, 2002·Journal of Child Neurology·Tracy A Glauser, John M Pellock
Mar 29, 2002·Journal of Child Neurology·Martina Bebin
Oct 26, 1999·Epilepsia·I E Leppik
Feb 21, 2006·British Journal of Clinical Pharmacology·Emilio Perucca
Dec 16, 1998·Therapeutic Drug Monitoring·T Mimaki
Jan 24, 2002·Therapeutic Drug Monitoring·Houda HachadRene H Levy
Apr 9, 2005·CNS Drugs·James E Frampton, Lesley J Scott
Mar 5, 2019·Metabolomics : Official Journal of the Metabolomic Society·J C Martínez-ÁvilaA M Borobia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.